A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study.
Shigenori HirumaFumika ShigiyamaShinji HisatakeSunao MizumuraNobuyuki ShiragaMasaaki HoriTakanori IkedaTakahisa HiroseNaoki KumashiroPublished in: Cardiovascular diabetology (2021)
UMIN000026340; registered on February 28, 2017. https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000030257.